Indeed, both ghrelin and echinacoside were proposed to be therapeutic drugs in Alzheimer’s disease and Parkinson’s disease [3,4,8,25,26,27]. The gene discussed is GHRL; the disease is early-onset autosomal dominant Alzheimer disease.